Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717586 · ClinicalTrials.gov registry record · Phase 1
Pravastatin for Prevention of Preeclampsia
A Phase 1 study of Preeclampsia, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 3
- Study locations
NCT01717586: Completed Phase 1 study of Preeclampsia, sponsored by The University of Texas Medical Branch, Galveston.
NCT01717586 is a Phase 1 study of Preeclampsia that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 48 participants, below the 1,125-participant average among 48 other Preeclampsia trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01717586, a Phase 1 study of Preeclampsia, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary purpose of this pilot study is to determine the pharmacokinetic (PK) parameters and collect preliminary safety data for pravastatin when used as a prophylactic daily treatment in pregnant women at high risk of preeclampsia.
Primary Outcome
The presence of side effects and adverse events will be assessed at each study visit by: * a symptoms checklist * any other report of adverse events * at select visits: laboratory testing for liver function test(LFT) and creatine kinase(CK)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pravastatin
Study Locations (3)
Illinois
- Northwestern University - Chicago
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-08 |
| Est. Completion | 2024-02-12 |
| Phase | Phase 1 |
What the finished NCT01717586 record still lists
NCT01717586 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,125-participant average among 48 other Preeclampsia trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01717586 reports a single indexed study location in Illinois, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT01717586 about?
NCT01717586 is a clinical study titled "Pravastatin for Prevention of Preeclampsia". The primary purpose of this pilot study is to determine the pharmacokinetic (PK) parameters and collect preliminary safety data for pravastatin when used as a prophylactic daily treatment in pregnant women at high risk of preeclampsia.
What is the current status of trial NCT01717586?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2012-08. Estimated completion is 2024-02-12.
What conditions does trial NCT01717586 study?
This clinical trial studies the following conditions: Preeclampsia.
What interventions are being tested in trial NCT01717586?
The interventions under investigation include: Placebo (DRUG), Pravastatin (DRUG).
Who is sponsoring clinical trial NCT01717586?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01717586 being conducted?
This trial has 3 study locations across Illinois, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01717586's enrollment target sits among peer trials
48 42nd of 48 higher than 7 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia